Centocor ( CNTO ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Centocor ( CNTO )

CNTO 0.00001000

0.0%

Mar 7 3:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Thean who wrote (13)	8/2/1996 8:14:00 AM
From: PawPr	of 965

I agree with your interpretation of the data. As I said in my earlier posting, in one to two years investors will look on Centocor with the same repect they show now for Amgen and Biogen. ReoPro will likely eventually be used routinely for most angioplasties, not just in high risk patients, creating an enormous recurring source of revenue for the company ( akin to Amgen's Neupogen, used to treat chemotherapy-induced bone marrow suppression ).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next